PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)
$4.08 -0.32 (-7.2727%)
Analysed PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) News Sources
Myriad Genetics And 2 Other Penny Stocks To Watch Closely
06-04-2026
yahoo.com
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
17-03-2026
yahoo.com
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
10-03-2026
yahoo.com
Sana Biotechnology (SANA) Appoints Industry Veteran Brian Piper as New CFO
26-02-2026
yahoo.com
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
03-02-2026
yahoo.com
Definitive Healthcare And 2 Other Promising Penny Stocks
28-01-2026
yahoo.com
Retail investors in Prelude Therapeutics Incorporated (NASDAQ:PRLD) are its biggest bettors, and their bets paid off as stock gained 12% last week
26-01-2026
yahoo.com
December 2025's Intriguing Stocks Priced Below Estimated Value
30-12-2025
yahoo.com
3 Promising Penny Stocks With A Market Cap Below $400M
30-12-2025
yahoo.com
Celsius Holdings Among 3 Value Stocks Trading Below Estimated Worth
30-12-2025
yahoo.com
What is the current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?
The current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is $4.08.
PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) absolute price change since previous trading day?
The absolute price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is $-0.32.
PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) percentage price change since previous trading day?
The percentage price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is -7.2727%.
What is the most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?
The most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?
The most recent sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is .
SEC-8K** Filing Available For PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.